JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BASSETT, A. L.
Right arrow Articles by HOFFMAN, B. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BASSETT, A. L.
Right arrow Articles by HOFFMAN, B. F.
Journal of Pharmacology And Experimental Therapeutics, Vol. 173, Issue 2, 336-343, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


"PROTECTIVE" ACTION OF DIPHENYLHYDANTOIN ON CANINE PURKINJE FIBERS DURING HYPOXIA

ARTHUR L. BASSETT 1, J. THOMAS BIGGER JR. 1, and BRIAN F. HOFFMAN 1

1 Departments of Pharmacology and Medicine, College of Physicians and Surgeons, Columbia University, New York, New York

Intracellular microelectrode recording techniques were used to elucidate the mechanism of antiarrhythmic action of diphenylhydantoin (DPH) in isolated canine Purkinje fibers during periods of hypoxia induced by 95% nitrogen-5% carbon dioxide. Hypoxia caused a fall in resting and action potential amplitude and in the maximum rate of rise (Vmax) of phase zero of the Purkinje fiber action potential. In six experiments, the mean time to one-half of control phase zero Vmax was 52 ± 10.4 minutes (mean ± S.E.) during hypoxia and 110 ± 15.1 minutes during hypoxia and intervention with DPH (10-8 M) (P < .005). DPH (10-7 M) transiently improved phase zero Vmax and conduction when these characteristics were depressed during hypoxia. It is suggested that the ability of DPH to delay significantly the decrease in Vmax of phase zero of the Purkinje fiber action potential induced by hypoxia may partially explain its effectiveness in abolishing ventricular arrhythmias resulting from occlusion of coronary arteries.

Submitted on November 28, 1969
Accepted on February 24, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.